3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
beta-Thalassemia
1
Thalassemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Large Granular Lymphocytic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Anemia, Sickle Cell
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Vincristine
3
Temozolomide
3
Specimen Handling
3
Irinotecan
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Radiotherapy
2
temsirolimus
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
erdafitinib
1
cabozantinib
1
atezolizumab
1
Vinorelbine
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
thymoglobulin
×
30 days
×
Clear all
No trials found.